Aktis Oncology, Inc. Common stock Financial Flexibility Index
Aktis Oncology, Inc. Common stock financial flexibility index. Aktis Oncology, Inc. Common stock (AKTS) has a Financial Flexibility Index of -0.03x as of December 2024. Free cash flow of $-10.57 Million (operating CF $-12.80 Million minus capex $2.23 Million) represents 0% of total liabilities ($413.98 Million). See AKTS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Aktis Oncology, Inc. Common stock (2014–2024)
Financial flexibility index of Aktis Oncology, Inc. Common stock from 2014 to 2024. Historical Financial Flexibility Index trend for Aktis Oncology, Inc. Common stock across 21 annual periods. Explore Aktis Oncology, Inc. Common stock (AKTS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Aktis Oncology, Inc. Common stock Financial Flexibility Index by Year (2014–2024)
Aktis Oncology, Inc. Common stock financial flexibility index by year from 2014 to 2024. Year-by-year free cash flow to debt coverage for Aktis Oncology, Inc. Common stock. For the full cash flow conversion analysis, see cash efficiency ratio of Aktis Oncology, Inc. Common stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.04x | $17.62 Million | $14.76 Million | $413.98 Million | ▲ +115.7% |
| 2024 | -0.27x | $-34.35 Million | $-40.35 Million | $126.83 Million | ▼ -74.1% |
| 2023 | -0.16x | $-26.24 Million | $-30.00 Million | $168.66 Million | ▲ +70.8% |
| 2023 | -0.53x | $-33.44 Million | $-44.82 Million | $62.68 Million | ▼ -431.3% |
| 2022 | -0.10x | $-15.82 Million | $-18.12 Million | $157.55 Million | ▲ +66.7% |
| 2022 | -0.30x | $-17.48 Million | $-45.20 Million | $57.91 Million | ▲ +0.0% |
| 2021 | -0.30x | $-17.48 Million | $-45.20 Million | $57.91 Million | ▲ +86.4% |
| 2021 | -2.22x | $-16.87 Million | $-29.36 Million | $7.58 Million | ▼ -486.6% |
| 2020 | -0.38x | $-11.35 Million | $-21.30 Million | $29.94 Million | ▲ +0.0% |
| 2020 | -0.38x | $-11.35 Million | $-21.30 Million | $29.94 Million | ▲ +34.5% |
| 2019 | -0.58x | $-12.74 Million | $-17.67 Million | $21.99 Million | ▲ +0.0% |
| 2019 | -0.58x | $-12.74 Million | $-17.67 Million | $21.99 Million | ▼ -24.7% |
| 2018 | -0.46x | $-7.18 Million | $-14.20 Million | $15.46 Million | ▲ +0.0% |
| 2018 | -0.46x | $-7.18 Million | $-14.20 Million | $15.46 Million | ▲ +62.9% |
| 2017 | -1.25x | $-3.86 Million | $-5.55 Million | $3.08 Million | ▲ +0.0% |
| 2017 | -1.25x | $-3.86 Million | $-5.55 Million | $3.08 Million | ▼ -122.2% |
| 2016 | -0.56x | $-1.05 Million | $-1.10 Million | $1.87 Million | ▲ +0.0% |
| 2015 | -0.56x | $-1.05 Million | $-1.10 Million | $1.87 Million | ▲ +78.7% |
| 2015 | -2.65x | $-868.32K | $-980.04K | $327.66K | ▲ +0.0% |
| 2014 | -2.65x | $-868.32K | $-980.04K | $327.66K | ▲ +97.0% |
| 2014 | -88.17x | $-26.98K | $-26.98K | $306.00 | — |